Skip to main content

MoneyWorks4Me

Gland Pharma informs about press release

03 Nov 2026 Evaluate
Gland Pharma has informed that it enclosed announcement regarding the receipt of USFDA approval for Methylprednisolone Acetate Injectable Suspension USP, 40 mg/mL and 80 mg/mL Single-Dose Vials and 200 mg/5 mL (40 mg/mL), 400 mg/10 mL (40 mg/mL), and 400 mg/5 mL (80 mg/mL) Multiple-Dose Vials.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1771.95
Dr. Reddys Labs. 1370.00
Cipla 1392.20
Lupin 2012.00
Zydus Lifesciences 1239.00
View more..